X. Yu

A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial

B. Monk, J. Chan, T. Herzog, 2012 .

Is it more cost-effective to use bevacizumab in the primary treatment setting or at recurrence? An economic analysis

B. Monk, A. Caughey, J. Chan, 2011 .

Predicting RT-induced pulmonary symptoms based on the dose to the superior vs. inferior lung in patients irradiated for lung cancer

R. Jaszczak, R. Coleman, L. Marks, 2003 .

The impact of irradiated left ventricular volume on the incidence of radiation-induced cardiac perfusion changes

R. Coleman, L. Marks, D. Hollis, 2003 .

The impact of pre-radiotherapy surgery on radiation-induced lung injury.

S. Zhou, L. Marks, D. Hollis, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium

M. Socinski, R. Clough, M. Anscher, 2004 .

Persistence of radiation (RT)-induced cardiac perfusion defects 3-5 years post RT.

D. Hollis, P. Hardenbergh, S. Borges-Neto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.